Trial Points to Best Practices for Inhaled Insulin in Type 1 Diabetes
Med Page Today
JUNE 23, 2024
(MedPage Today) -- ORLANDO -- For type 1 diabetes patients, switching from an insulin pump or multiple daily injections to inhaled insulin (Afrezza) maintained glycemic control -- for those who used it as intended, the INHALE 3 trial showed.
Let's personalize your content